PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.\', \'Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA.\', \'Oncology Department, CHUV, Lausanne, Vaud, Switzerland.\', \'Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.\', \'Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.\', \'Cancer Program, Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142, USA. Electronic address: painter@broadinstitute.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1535-6108(20)30492-X10.1016/j.ccell.2020.09.018
?:hasPublicationType
?:journal
  • Cancer cell
is ?:pmid of
?:pmid
?:pmid
  • 33049215
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 12.7
?:rankingScore_hIndex
  • 284
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 and Cancer: Current Challenges and Perspectives.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all